Adults 40 to 70, any sex, with Visual Acuity. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Vision ScoresPrimary· 2-Week Follow-up
Overall quality of vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.
Period 1
Group
Value
95% CI
Test
42.2
± 13.68
Control
55.3
± 22.99
Period 2
Group
Value
95% CI
Test
52.4
± 22.77
Control
41.8
± 14.92
Vision Scores Comparison Between Test and ControlPrimary· 2-Week Follow-up
Overall quality of vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.
Period 1
Group
Value
95% CI
Test
42.2
± 13.68
Control
55.3
± 22.99
Period 2
Group
Value
95% CI
Test
52.4
± 22.77
Control
41.8
± 14.92
Sponsor's own description
This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible hyperopic subjects will be targeted to complete this study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT03581825 — Clinical Evaluation of a Reusable Multifocal Optical Design in a Presbyopic Population
· NA
· completed
Other recruiting trials for Visual Acuity
Currently open trials in the same condition.
NCT07443215 — Evaluation of Effect of Scatter on Visual Performance
· NA
· recruiting
NCT07135193 — Evaluation of the Protective Effects of Cordyceps Cicadae on Visual Function and Anti-Fatigue Performance in Esports Ath
· NA
· active not recruiting
NCT07085533 — Natural History Study of Inherited Retinal Diseases
· recruiting
NCT07135180 — Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups
· NA
· active not recruiting
NCT04632901 — A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
· active not recruiting
Other Johnson & Johnson Vision Care, Inc. trials
Trials by the same sponsor.
NCT07443215 — Evaluation of Effect of Scatter on Visual Performance
· NA
· recruiting
NCT07174596 — Evaluation of Approved Contact Lenses
· NA
· completed
NCT07076160 — Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses
· NA
· completed
NCT06967129 — Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process
· NA
· completed
NCT06864858 — Clinical Evaluation of Two Cosmetic Contact Lenses
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Vision Care, Inc.
Last refreshed: 13 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03586648.